vs
Side-by-side financial comparison of BELDEN INC. (BDC) and SELECT MEDICAL HOLDINGS CORP (SEM). Click either name above to swap in a different company.
SELECT MEDICAL HOLDINGS CORP is the larger business by last-quarter revenue ($1.4B vs $720.1M, roughly 1.9× BELDEN INC.). BELDEN INC. runs the higher net margin — 9.4% vs 1.4%, a 8.0% gap on every dollar of revenue. On growth, BELDEN INC. posted the faster year-over-year revenue change (8.1% vs 6.4%). BELDEN INC. produced more free cash flow last quarter ($121.3M vs $5.2M). Over the past eight quarters, BELDEN INC.'s revenue compounded faster (9.2% CAGR vs 2.8%).
Belden Inc. is an American, multinational, publicly traded company specializing in the design, manufacture, and distribution of end-to-end networking, security and connectivity products. The company serves the Industrial Automation Solutions, Smart Buildings and Broadband & 5G markets.
Select Medical is a healthcare company based in Pennsylvania. It owns long-term acute care and inpatient rehabilitation hospitals, as well as occupational health and physical therapy clinics. Select Medical is a subsidiary of Select Medical Holdings, which is listed on the New York Stock Exchange.
BDC vs SEM — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $720.1M | $1.4B |
| Net Profit | $67.9M | $20.2M |
| Gross Margin | 36.6% | — |
| Operating Margin | 12.2% | 4.6% |
| Net Margin | 9.4% | 1.4% |
| Revenue YoY | 8.1% | 6.4% |
| Net Profit YoY | 16.3% | 225.7% |
| EPS (diluted) | $1.70 | $0.17 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $720.1M | — | ||
| Q4 25 | $720.1M | $1.4B | ||
| Q3 25 | $698.2M | $1.4B | ||
| Q2 25 | $672.0M | $1.3B | ||
| Q1 25 | $624.9M | $1.4B | ||
| Q4 24 | $666.0M | $1.3B | ||
| Q3 24 | $654.9M | $1.3B | ||
| Q2 24 | $604.3M | $1.3B |
| Q1 26 | $67.9M | — | ||
| Q4 25 | $67.9M | $20.2M | ||
| Q3 25 | $56.7M | $28.8M | ||
| Q2 25 | $61.0M | $40.6M | ||
| Q1 25 | $51.9M | $56.7M | ||
| Q4 24 | $58.4M | $-16.1M | ||
| Q3 24 | $53.7M | $55.6M | ||
| Q2 24 | $49.0M | $77.6M |
| Q1 26 | 36.6% | — | ||
| Q4 25 | 36.6% | — | ||
| Q3 25 | 37.7% | — | ||
| Q2 25 | 38.5% | — | ||
| Q1 25 | 39.3% | — | ||
| Q4 24 | 37.5% | — | ||
| Q3 24 | 37.3% | — | ||
| Q2 24 | 37.5% | — |
| Q1 26 | 12.2% | — | ||
| Q4 25 | 12.2% | 4.6% | ||
| Q3 25 | 10.9% | 5.4% | ||
| Q2 25 | 11.8% | 6.5% | ||
| Q1 25 | 11.6% | 8.3% | ||
| Q4 24 | 10.4% | 1.6% | ||
| Q3 24 | 11.5% | 4.3% | ||
| Q2 24 | 11.4% | 5.8% |
| Q1 26 | 9.4% | — | ||
| Q4 25 | 9.4% | 1.4% | ||
| Q3 25 | 8.1% | 2.1% | ||
| Q2 25 | 9.1% | 3.0% | ||
| Q1 25 | 8.3% | 4.2% | ||
| Q4 24 | 8.8% | -1.2% | ||
| Q3 24 | 8.2% | 4.4% | ||
| Q2 24 | 8.1% | 6.1% |
| Q1 26 | $1.70 | — | ||
| Q4 25 | $1.70 | $0.17 | ||
| Q3 25 | $1.41 | $0.23 | ||
| Q2 25 | $1.53 | $0.32 | ||
| Q1 25 | $1.27 | $0.44 | ||
| Q4 24 | $1.41 | $-0.12 | ||
| Q3 24 | $1.30 | $0.43 | ||
| Q2 24 | $1.19 | $0.60 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $389.9M | $26.5M |
| Total DebtLower is stronger | $1.3B | $1.8B |
| Stockholders' EquityBook value | $1.3B | $1.7B |
| Total Assets | — | $5.9B |
| Debt / EquityLower = less leverage | 1.02× | 1.06× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $389.9M | — | ||
| Q4 25 | $389.9M | $26.5M | ||
| Q3 25 | $314.3M | $60.1M | ||
| Q2 25 | $301.5M | $52.3M | ||
| Q1 25 | $259.0M | $53.2M | ||
| Q4 24 | $370.3M | $59.7M | ||
| Q3 24 | $323.0M | $191.5M | ||
| Q2 24 | $564.8M | $111.2M |
| Q1 26 | $1.3B | — | ||
| Q4 25 | — | $1.8B | ||
| Q3 25 | — | $1.7B | ||
| Q2 25 | — | $1.8B | ||
| Q1 25 | — | $1.8B | ||
| Q4 24 | — | $1.7B | ||
| Q3 24 | — | $3.1B | ||
| Q2 24 | — | $3.6B |
| Q1 26 | $1.3B | — | ||
| Q4 25 | $1.3B | $1.7B | ||
| Q3 25 | $1.2B | $1.7B | ||
| Q2 25 | $1.2B | $1.7B | ||
| Q1 25 | $1.2B | $1.7B | ||
| Q4 24 | $1.3B | $1.7B | ||
| Q3 24 | $1.2B | $1.9B | ||
| Q2 24 | $1.2B | $1.4B |
| Q1 26 | — | — | ||
| Q4 25 | $3.5B | $5.9B | ||
| Q3 25 | $3.4B | $5.7B | ||
| Q2 25 | $3.4B | $5.7B | ||
| Q1 25 | $3.3B | $5.7B | ||
| Q4 24 | $3.3B | $5.6B | ||
| Q3 24 | $3.3B | $8.0B | ||
| Q2 24 | $3.5B | $7.9B |
| Q1 26 | 1.02× | — | ||
| Q4 25 | — | 1.06× | ||
| Q3 25 | — | 1.03× | ||
| Q2 25 | — | 1.10× | ||
| Q1 25 | — | 1.03× | ||
| Q4 24 | — | 1.01× | ||
| Q3 24 | — | 1.62× | ||
| Q2 24 | — | 2.54× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $354.9M | $64.3M |
| Free Cash FlowOCF − Capex | $121.3M | $5.2M |
| FCF MarginFCF / Revenue | 16.8% | 0.4% |
| Capex IntensityCapex / Revenue | 18.9% | 4.2% |
| Cash ConversionOCF / Net Profit | 5.23× | 3.19× |
| TTM Free Cash FlowTrailing 4 quarters | $364.7M | $117.2M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $354.9M | — | ||
| Q4 25 | $160.4M | $64.3M | ||
| Q3 25 | $105.0M | $175.3M | ||
| Q2 25 | $82.0M | $110.3M | ||
| Q1 25 | $7.4M | $-3.5M | ||
| Q4 24 | $174.7M | $125.4M | ||
| Q3 24 | $91.7M | $181.0M | ||
| Q2 24 | $83.0M | $278.2M |
| Q1 26 | $121.3M | — | ||
| Q4 25 | $121.3M | $5.2M | ||
| Q3 25 | $65.3M | $122.2M | ||
| Q2 25 | $56.9M | $45.6M | ||
| Q1 25 | $-24.8M | $-55.8M | ||
| Q4 24 | $116.4M | $62.0M | ||
| Q3 24 | $67.2M | $130.3M | ||
| Q2 24 | $61.0M | $222.6M |
| Q1 26 | 16.8% | — | ||
| Q4 25 | 16.8% | 0.4% | ||
| Q3 25 | 9.4% | 9.0% | ||
| Q2 25 | 8.5% | 3.4% | ||
| Q1 25 | -4.0% | -4.1% | ||
| Q4 24 | 17.5% | 4.7% | ||
| Q3 24 | 10.3% | 10.2% | ||
| Q2 24 | 10.1% | 17.4% |
| Q1 26 | 18.9% | — | ||
| Q4 25 | 5.4% | 4.2% | ||
| Q3 25 | 5.7% | 3.9% | ||
| Q2 25 | 3.7% | 4.8% | ||
| Q1 25 | 5.2% | 3.9% | ||
| Q4 24 | 8.8% | 4.8% | ||
| Q3 24 | 3.7% | 4.0% | ||
| Q2 24 | 3.6% | 4.3% |
| Q1 26 | 5.23× | — | ||
| Q4 25 | 2.36× | 3.19× | ||
| Q3 25 | 1.85× | 6.09× | ||
| Q2 25 | 1.34× | 2.72× | ||
| Q1 25 | 0.14× | -0.06× | ||
| Q4 24 | 2.99× | — | ||
| Q3 24 | 1.71× | 3.25× | ||
| Q2 24 | 1.69× | 3.59× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BDC
Segment breakdown not available.
SEM
| Critical Illness Recovery Hospitals | $629.7M | 45% |
| Health Care Patient Service Non Medicare | $428.6M | 31% |
| Rehabilitation Hospitals | $339.2M | 24% |
